ACS Nano · 2015 · 322 citations · 35 references
PharmacyNuclear MedicineOncologyBiomedical ImagingDiagnostic ImagingNanomaterialsCancer NanomedicineInorganic NanoparticlesNanomedicinePhotothermal TherapyTheranostic NanoparticlesTumor ImagingCancer ImagingCancer Photothermal TherapyImaging-guided Photothermal TherapyInorganic NanomaterialsNanomaterials For Photothermal TherapyNanoparticle Imaging AgentsNanoparticle Imaging ProbesPhotothermal Ablation Of Tumors
Translation of nanoparticles (NPs) into clinical practice has been limited by toxic effects induced by nonspecific accumulation of NPs in healthy organs after systemic administration. The ideal NPs should accumulate in the target site, carry out their function, and then ultimately be eliminated from the body. Here, we show a single-compartment, multifunctional ultrasmall copper sulfide nanodot (CuS ND) that is rapidly cleared from the body. These CuS NDs have a hydrodynamic diameter of <6 nm, can efficiently absorb near-infrared light for photothermal ablation therapy, and stably incorporate the copper-64 radioisotope for noninvasive positron emission tomography (PET). Importantly, ∼95% of CuS NDs are excreted intact through the renal-urinary system within 24 h with minimal retention in the liver and the spleen. The ultrasmall CuS NDs accumulate in 4T1 tumors in Balb/c mice, as monitored by PET imaging, and mediate tumor ablation when combined with near-infrared light irradiation. As a first example of PET-visible, renal-clearable inorganic nanomaterials with peak absorption in the near-infrared region, CuS NDs represent a robust platform for cancer imaging and therapy.
35
Renal clearance of quantum dots
Hak Soo Choi, Wenhao Liu, Preeti Misra et al. · Nature Biotechnology · 2007 · 4.4K citations · Full text
Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy
Kai Yang, Shuai Zhang, Guoxin Zhang et al. · Nano Letters · 2010 · 2.4K citations